Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

June 16, 2014

Medically, Proteomics Advances Will Rival the Genetics Advances of the Last Ten Years

As the number of medically important proteins increases, the impact will be momentous, according to N. Leigh Anderson.

Medically, Proteomics Advances Will Rival the Genetics Advances of the Last Ten Years

N. Leigh Anderson, founder of the Plasma Proteome Institute and CEO of SISCAPA Assay Technologies.

Seventy percent of the decisions made by physicians today are influenced by results of diagnostic tests, according to N Leigh Anderson, founder of the Plasma Proteome Institute and CEO of SISCAPA Assay Technologies Imagine the changes that will come about when future diagnostics tests are more accurate, more useful, more ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.

Related content